+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Organs-on-chips Market Research Report by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4857886
  • Report
  • June 2020
  • Region: Global
  • 230 pages
  • 360iResearch
UP TO OFF
until Jul 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Organs-on-chips Market to Grow USD 84.09 Million by 2025, at a CAGR of 32.52%

FEATURED COMPANIES

  • AxoSim, Inc
  • CN Bio Innovations
  • HµREL Corporation
  • Kirkstall Ltd.
  • Nortis
  • SynVivo, Inc
  • MORE
The Global Organs-on-chips Market is expected to grow from USD 15.52 Million in 2019 to USD 84.09 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 32.52%.

Market Segmentation & Coverage:

This research report categorizes the Organs-on-chips to forecast the revenues and analyze the trends in each of the following sub-markets:

On the basis of Type, the Organs-on-chips Market is examined across Artery-on-a-chip, Brain-on-a-chip, Heart-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, and Skin-on-a-chip.

On the basis of Application, the Organs-on-chips Market is examined across Drug Discovery, Physiological Model Development, and Toxicology Research.

On the basis of End User, the Organs-on-chips Market is examined across Academic & Research Institutes, Cosmetics Industry, and Pharmaceutical & Biotechnology Companies.

On the basis of Geography, the Organs-on-chips Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Organs-on-chips Market including AxoSim, Inc, BioIVT, CN Bio Innovations, Emulate, Inc., HemoShear Therapeutics, LLC, HµREL Corporation, InSphero AG, Kirkstall Ltd., Mimetas, Nortis, Organovo, Inc., SynVivo, Inc, Tara Biosystems, and TissUse GmbH.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Organs-on-chips Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Organs-on-chips Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Organs-on-chips Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Organs-on-chips Market?
4. What is the competitive strategic window for opportunities in the Global Organs-on-chips Market?
5. What are the technology trends and regulatory frameworks in the Global Organs-on-chips Market?
6. What are the modes and strategic moves considered suitable for entering the Global Organs-on-chips Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AxoSim, Inc
  • CN Bio Innovations
  • HµREL Corporation
  • Kirkstall Ltd.
  • Nortis
  • SynVivo, Inc
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
2.3.1. Competitive Strategic Window

3. Executive Summary
3.1. Market Outlook
3.2. Type Outlook
3.3. Application Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Organs-on-chips Market, By Geography

5. Market Dynamics
5.1. Introduction
5.1.1. Drivers
5.1.1.1. Increasing focus on developing alternatives for animal testing models
5.1.1.2. Significant increase in research funding and venture capital investments for the development of organs-on-chips
5.1.1.3. Technological advancements and new products launches
5.1.1.4. Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers
5.1.1.5. Rising need for early detection of drug toxicity to minimize financial losses due to late-stage drug failure
5.1.1.6. Growing initiatives to increase awareness about organs-on-chips technologies
5.1.2. Restraints
5.1.2.1. Issues related to the incorporation of organs-on-chips technologies into existing workflows
5.1.3. Opportunities
5.1.3.1. Growing focus on drug discovery activities
5.1.3.2. Application of organs-on-chips in oncology research
5.1.3.3. Development of multiple-organs-on-a-chip models
5.1.4. Challenges
5.1.4.1. Complexity of organs-on-chips models
5.1.4.2. Dearth of skilled professionals

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations
6.3.1. Developments In The Testing Of Human Organs-On-Chips
6.3.2. Organ-On-Chip Technology In Space
6.3.3. Automated Monitoring Of Organs-On-Chips
6.3.4. 3D Printing Of Organs-On Chips
6.3.5. Investment In Integration Of Individual Organs-on-Chips Into Humans-on-Chips

7. Global Organs-on-chips Market, By Type
7.1. Introduction
7.2. Artery-on-a-chip
7.3. Brain-on-a-chip
7.4. Heart-on-a-chip
7.5. Kidney-on-a-chip
7.6. Lung-on-a-chip
7.7. Skin-on-a-chip

8. Global Organs-on-chips Market, By Application
8.1. Introduction
8.2. Drug Discovery
8.3. Physiological Model Development
8.4. Toxicology Research

9. Global Organs-on-chips Market, By End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Cosmetics Industry
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Organs-on-chips Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Organs-on-chips Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand

12. Europe, Middle East & Africa Organs-on-chips Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding

14. Company Usability Profiles
14.1. AxoSim, Inc
14.2. BioIVT
14.3. CN Bio Innovations
14.4. Emulate, Inc.
14.5. HemoShear Therapeutics, LLC
14.6. HµREL Corporation
14.7. InSphero AG
14.8. Kirkstall Ltd.
14.9. Mimetas
14.10. Nortis
14.11. Organovo, Inc.
14.12. SynVivo, Inc
14.13. Tara Biosystems
14.14. TissUse GmbH

15. Appendix
15.1. Discussion Guide
15.2. Edition Details
15.3. License Details
15.4. Pricing Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AxoSim, Inc
  • BioIVT
  • CN Bio Innovations
  • Emulate, Inc.
  • HemoShear Therapeutics, LLC
  • HµREL Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis
  • Organovo, Inc.
  • SynVivo, Inc
  • Tara Biosystems
  • TissUse GmbH
Note: Product cover images may vary from those shown
Adroll
adroll